Process Development and Manufacturing: EXPANSION OF MEDICINAL SIGNALING CELLS (HEPASTEM™) FOR LIVER REGENERATIVE THERAPY IN SERUM-FREE CONDITIONS

Autor: P. De Berdt, E. Deltour, E. Pauly, M. Najimi, E. Sokal

Publikováno v: Cytotherapy. 25:S177

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f8bb2f8f3d570130d8f0ed77b646bd02
https://doi.org/10.1016/s1465-3249(23)00469-3

Challenges in developing an off-the-shelf cell therapy for ACLF and NASH

Autor: J. Pinxteren, J. Scholasse, E. Deltour, F. Manzoni

Publikováno v: Cytotherapy. 21:S87

Background & Aim Promethera is a biopharma company focused on the research, development and commercialization of stem cell-based therapies and technologies for acute and chronic liver diseases. Our lead clinical program, an allogenic human liver deri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea74d79a3cca6103a2e015d897a684a3
https://doi.org/10.1016/j.jcyt.2019.03.513

Risk of acute liver injury in agomelatine and other antidepressant users in four european countries: a cohort and nested case–control study using automated health data sources

Autor: Lena Brandt, Rosa Morros, Emmanuelle Jacquot, Tania Schink, Jesper Hallas, Gabriel Perlemuter, Maria Giner-Soriano, Antje Timmer, Nicolas Deltour, Bruno Falissard, Jordi Castellsague, Anton Pottegård, Manel Pladevall-Vila, Jordi Cortés, Miguel Cainzos-Achirica, Maja Hellfritzsch, Beatriz Poblador-Plou, David Hägg, Alexandra Prados-Torres, Jaume Aguado, Johan Reutfors, Susana Perez-Gutthann, Joan Forns, Tammo Reinders

Publikováno v: Scientia
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Recercat. Dipósit de la Recerca de Catalunya
instname
CNS drugs, 33(4):383-395
CNS Drugs
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Pladevall-Vila, M, Pottegård, A, Schink, T, Reutfors, J, Morros, R, Poblador-Plou, B, Timmer, A, Forns, J, Hellfritzsch, M, Reinders, T, Hägg, D, Giner-Soriano, M, Prados-Torres, A, Cainzos-Achirica, M, Hallas, J, Brandt, L, Cortés, J, Aguado, J, Perlemuter, G, Falissard, B, Castellsagué, J, Jacquot, E, Deltour, N & Perez-Gutthann, S 2019, ' Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries : A Cohort and Nested Case-Control Study Using Automated Health Data Sources ', CNS Drugs, vol. 33, no. 4, pp. 383-395 . https://doi.org/10.1007/s40263-019-00611-9

Acute liver injury; Antidepressants; Case-control Lesió hepàtica aguda; Antidepressius; Control de casos Lesión hepática aguda; Antidepresivos; Control de casos Background Agomelatine is a melatonin receptor agonist and serotonin 5-HT2C receptor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936d1cae613f8e5d0bc01d45b6566e6e
http://scientiasalut.gencat.cat/handle/123456789/3836